Business Daily Media

The Times


.

Mabpharm Announces Proposed Listing on the Main Board of the Hong Kong Stock Exchange

  • Written by: ACN Newswire
Offer Price Set Between HK$1.50 to HK$1.95 per Share, To Raise Gross Proceeds Up to HK$1,528 MillionA Leading Biopharmaceutical Company in China, Focusing on the Research, Development and Production of New Drugs and Biosimilar for Cancers and Autoimmune DiseasesHONG KONG, May 20, 2019 - (ACN Newswire) - A leading biopharmaceutical company in...

Selling a Small Business in Australia: Understanding the Capital Gains Tax Concessions

For many Australian business owners, selling a business represents the reward for years—sometimes decades—of hard work. Unlike employees who may bu...

Australian businesses lean into global strategic partnerships (GCCs) for next wave of outsourcing

The Australian corporate landscape is undergoing a fundamental transformation in how it sources talent and innovation. While businesses have traditi...

The New Pressure Gap Crushing Small Businesses

Starting any business and making it prosper is a major undertaking. Part of the challenge is managing the uncertainty, but the financial pressures o...

Click Frenzy returns with a free EOFY sale event for retailers this month

New owners Gabby and Hezi Leibovich bring back Australia’s leading ecommerce sales event with Australia Post as Major Sponsor   Click Frenzy is ...

The 95 Per Cent Failure Rate Is Not An AI Problem

Most Australian SMEs I speak with are already having a go at AI. Some are running formal pilots, others have a team member quietly experimenting o...

New AR tech helping to solve field service skills crisis

AI-enabled augmented reality (AR) smart glasses are emerging as a new practical solution to fill a shortage of field service technicians maintaini...